Peter Cuthbertson
12PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 18, 2025
Use of Human Chronic Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in a Xenogeneic Mouse Model of Graft-Versus-Host Disease.Chloe Sligar, Nicolas R Tomasiello, Peter Cuthbertson
|Mar 18, 2024
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice.Chloe Sligar, Ellie Reilly, Peter Cuthbertson
|May 16, 2023
Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft-versus-host disease development in humanized mice treated with post-transplant cyclophosphamide.Chloe Sligar, Peter Cuthbertson, Nicole A Miles
|Sep 23, 2022
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist.Peter Cuthbertson, Amal Elhage, Dena Al-Rifai
|Aug 22, 2022
Insights into mechanisms of graft-versus-host disease through humanised mouse models.Amal Elhage, Chloe Sligar, Peter Cuthbertson
|Jul 01, 2022
Humanized Mouse Model to Study the P2X7 Receptor in Graft-Versus-Host Disease.Debbie Watson, Sam R Adhikary, Peter Cuthbertson
Pageof 2
Frequent Collaborators
12 joint publications
Ronald Sluyter
8 joint publications
Debbie Watson
6 joint publications
Chloe Sligar
6 joint publications
Amal Elhage
5 joint publications
Sam R Adhikary
3 joint publications
Stephen I Alexander
3 joint publications
Nicholas J Geraghty
3 joint publications
Katrina M Bird
2 joint publications
Ross J Turner
1 joint publications
Taylor L Nelson
